Prevalence of sarcopenia after remission of hypercortisolism and its impact on HRQoL.

Luciana Martel-DuguechAlicia Alonso-JimenezHelena BascuñanaJordi Díaz-ManeraJaume LlaugerClaudia Nuñez-PeraltaPaula MontesinosSusan M WebbElena Valassi

Published in: Clinical endocrinology (2021)

Sarcopenia is common in patients with CS in long-term remission, and associated with impaired quality of life. The SI is a potential biomarker allowing clinicians to identify patients at high risk of muscle dysfunction.

Keyphrases

skeletal muscle
disease activity
ulcerative colitis
risk factors
community dwelling
oxidative stress
palliative care
systemic lupus erythematosus
rheumatoid arthritis